This content is only available for ASCRS Members
This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.
Current treatment options for end stage ocular surface disease include OOKP, which is a tedious two staged procedure or a type 2 KPRO, which is not commercially available in our part of the world. We describe the innovative use of a modified type 1 KPRO in 5 eyes with bone dry ocular surface, wherein the patient’s own pannus or mucous membrane graft is used to prevent corneal desiccation and melt.
Filed Under
Cornea
keratoprosthesis
Boston Kpro
Stevens-Johnson syndrome
ocular surface disease
surgical technique
challenging case
2020 film
View more Films
This film was submitted to the 38th Annual ASCRS Film Festival within the 2020 ASCRS Virtual Annual Meeting..